Navigation Links
Cyberkinetics Requests FDA to Sell Nerve Growth Stimulation System

Cyberkinetics, Inc, winner of the Medgadget "Most Sci-Fi Sounding Company Name" Award, has asked the FDA for permission to market// their Andara OFS nerve growth stimulation system.

According to Cyberkinetics, “Cyberkinetics' Andara? OFS? System consists of a battery-powered device about the size of a cardiac pacemaker with six electrical leads. Three of the leads are attached to the vertebrae at a distance of two disk-segments above the area of injury, and three are attached to the vertebrae at a distance of two disk-segments below the injury. By applying an oscillating, low-voltage, direct current of electricity to the areas above and below a spinal cord injury, the Andara? OFS? System creates an electrical field that surrounds the injury and stimulates the nerves surrounding the spinal cord to grow and form new connections that can restore sensory and motor function. The Andara? OFS? System is an investigational device. It is not currently approved for sale and is available only through participation in a clinical study.

Cyberkinetics has filed an application for Humanitarian Use Device status from the FDA. If the application is successful, Cyberkinetics could market the device commercially in late 2007.

Basically, the new humanitarian exemption would mean that they could actually sell the device, rather than only use it through clinical trials.

Source-Bio-Bio Technology
'"/>




Page: 1

Related medicine news :

1. Canadian Street Prostitutes Requests Protection
2. New Zealand Requests Details from Britain about ‘Black Sheep
3. Patients Requests for Antidepressants can Influence Physician Evaluation of Depression
4. FDA Requests Label Change for All Sleep Disorder Drug Products
5. Epilepsy Drug Helps Diabetic Nerve Damage
6. World’s First Nerve Stem Cells Produced
7. Children With Epilepsy Can Be Treated With Nerve Stimulation
8. FDA Approved Nerve-Stimulation Therapy Now Available In New York
9. Doctors Finish Mother-To-Son Nerve Surgery
10. Stem Cells From Hair Follicle To Repair Nerve Damage
11. Nerve regeneration for Spinal cord injuries
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , has ... bony lump located on the forehead usually attributed to a facial fracture. Their appearance ... Dr. Shah has discovered an approach that is minimally invasive. He is an expert ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Dudnyk has ... identity emphasizes the agency’s conviction that the full potential of specialty and orphan brands ... equally appreciated and aligned. , “The Unifying Effect is at the heart of ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Hong Kong Polytechnic ... 3D printing facility among higher education institutions in Hong Kong to support teaching, learning ... of the range and quantity of facilities in Hong Kong. , With an ...
(Date:4/21/2017)... ... April 21, 2017 , ... Airway ... new partnership with the highly regarded and well renowned Asian distributor, Discovery Sleep. ... & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen Airway’s presence ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Providing for loved ... the estate planning process, or where to even begin. “Now more than ever there ... are to properly protect yourself and your family,” said attorney Lisa Edgar Dickman, founder ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: